Académique Documents
Professionnel Documents
Culture Documents
Brand
Name
BioThrax
Organism Used
Vaccine
Anthrax Vaccine
Adsorbed (AVA)
Organism
B. anthracis Vollum
strain known as
V770-NP1-R
How is it
attenuated/inactivated?
Diseases Prevented:
Anthrax
Pre-Exposure Prophylaxis:
Schedule
Primary
Series
Booster
Series
Route of
Administration
Dosing Schedule
Intramuscular
Intramuscular
6 and 12 months
after completion of
the primary series
and at 12-month
intervals thereafter
Subcutaneous
Dosing Schedule
0, 2, and 4 weeks
post-exposure
combined with
antimicrobial therapy
Age Group
18 to 65 years of age who may be at
risk of coming in contact with anthrax
because of their job:
Certain laboratory workers who work
with anthrax
Some people who handle animals or
animal products, such as some
veterinarians
Some members of the United States
military